3-nitropyridine analogues as novel microtubule-targeting agents
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307153 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jean Herman und 15 weiteren Autor:innen. Beteiligte Einrichtung: 4AZA Biosciences, Leuven, Belgium. Hauptthemen laut MEDLINE: Microtubules, Tubulin, Pyridines, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Microtubule-targeting agents are an important class of anti-cancer drugs; their full potential is however not realized because of significant myelotoxicity and neurotoxicity. We here report 3-nitropyridine analogues as a novel group of microtubule-targeting agents with potent anti-cancer effects against a broad range of cancer types. We show that these 3-nitropyridines induce cell cycle arrest in the G2-M phase and inhibit tubulin polymerization by interacting with tubulin. Determination of the tubulin–4AZA2996 structure by X-ray crystallography demonstrated that this class of compounds binds to the colchicine-site of tubulin. Furthermore, the anti-cancer effect was demonstrated both in vitro and in vivo in a murine heterotopic xenograft model of colon cancer. When administered intravenously, 4AZA2891 effectively inhibited cancer growth. Whereas 3-nitropyridine compounds do not induce myelotoxicity at pharmacological doses, the neurotoxicity associated with microtubule-targeting agents is still present.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 4AZA Biosciences, Leuven, Belgium.
- Interface Valorisation Platform (IVAP), KU Leuven, Leuven, Belgium.
- Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
- Department of Pediatric Nephrology and Solid Organ Transplantation, University Hospitals Leuven, Leuven, Belgium.
- Molecular Genetics and Therapeutics in Virology and Oncology Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
- Laboratory of Biomolecular Research, Center for Life Sciences, Paul Scherrer Institut, Würenlingen, Switzerland.
ORCID-Profile: Andrea E Prota, Leentje Persoons, Dirk Daelemans
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Herman, J., Vanstreels, E., Bardiot, D., Prota, A. E., Gaillard, N., Gao, L. J., Vercruysse, T., Persoons, L., Daems, T., Waer, M., Herdewijn, P., Louat, T., Steinmetz, M. O., De Jonghe, S., Sprangers, B., & Daelemans, D. (2024). 3-nitropyridine analogues as novel microtubule-targeting agents. PLOS ONE. https://doi.org/10.1371/journal.pone.0307153
Vancouver
Herman J, Vanstreels E, Bardiot D, Prota AE, Gaillard N, Gao LJ, et al. 3-nitropyridine analogues as novel microtubule-targeting agents. PLOS ONE. 2024. doi:10.1371/journal.pone.0307153
BibTeX
@article{Herman2024,
author = {Herman, Jean and Vanstreels, Els and Bardiot, Dorothée and Prota, Andrea E and Gaillard, Natacha and Gao, Ling-Jie and Vercruysse, Thomas and Persoons, Leentje and Daems, Tinne and Waer, Mark and Herdewijn, Piet and Louat, Thierry and Steinmetz, Michel O and De Jonghe, Steven and Sprangers, Ben and Daelemans, Dirk},
title = {3-nitropyridine analogues as novel microtubule-targeting agents},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307153}
}
EUVIMED